
AstraZeneca is to work with Harvard University’s department of stem cell and regenerative biology to develop new treatments in diabetes. …

AstraZeneca has signed a two-year collaboration with an academic institution – affiliated to the illustrious universities MIT and Harvard – …
Boehringer Ingelheim has established a translational research collaboration with the presidents and fellows of Harvard College. The aim of the …

